BONY MATHEW: Open Payments
NPI 1174282099 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 48 payments from 12 companies in 2025. Trend: 2023 $243 · 2024 $560 · 2025 $1,396
Food & beverage: $1,307Education: $89
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $521 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $217 |
| Gilead Sciences, Inc. | 8 | $175 |
| Janssen Biotech, Inc. | 5 | $168 |
| Ardelyx, Inc. | 4 | $83 |
| ABBVIE INC. | 4 | $81 |
| Intercept Pharmaceuticals, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 4 | $30 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, IBSRELA, MAVYRET, OCALIVA, VOQUEZNA, SUTAB.
Industry payments across CA — which companies pay providers there.
